Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-14-002818
Filing Date
2014-05-20
Accepted
2014-05-20 09:02:56
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ppch_10q.htm 10-Q 589631
2 CERTIFICATION ppch_ex311.htm EX-31.1 16804
3 CERTIFICATION ppch_ex312.htm EX-31.2 16885
4 CERTIFICATION ppch_ex321.htm EX-32.1 6812
5 CERTIFICATION ppch_ex322.htm EX-32.2 6587
  Complete submission text file 0001354488-14-002818.txt   2354273

Data Files

Seq Description Document Type Size
6 ppnc-20140331.xml EX-101.INS 189191
7 ppnc-20140331.xsd EX-101.SCH 27041
8 ppnc-20140331_cal.xml EX-101.CAL 41977
9 ppnc-20140331_lab.xml EX-101.LAB 152032
10 ppnc-20140331_pre.xml EX-101.PRE 103488
11 ppnc-20140331_def.xml EX-101.DEF 16046
Mailing Address PO BOX 114 CAMBERWELL, VICTORIA C3 3124
Business Address PO BOX 114 CAMBERWELL, VICTORIA C3 3124 61 3 9208 4128
Propanc Health Group Corp (Filer) CIK: 0001517681 (see all company filings)

EIN.: 300662986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 14856484
SIC: 2834 Pharmaceutical Preparations